IP
40
4
SYK
42
-13
FOXA
38
3
GD
66
2
LNC
49
9
MHK
55
2
AEP
56
3
GME
89
15
WRK
75
2
MNST
65
5
FRT
58
-5
EMR
39
2
RL
76
6
IVZ
43
5
KLAC
65
2
NSC
42
2
O
44
2
NEM
53
-2
DRI
57
3
FLS
67
2
IP
40
4
SYK
42
-13
FOXA
38
3
GD
66
2
LNC
49
9
MHK
55
2
AEP
56
3
GME
89
15
WRK
75
2
MNST
65
5
FRT
58
-5
EMR
39
2
RL
76
6
IVZ
43
5
KLAC
65
2
NSC
42
2
O
44
2
NEM
53
-2
DRI
57
3
FLS
67
2
Financhill
Back

Catalyst Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
42

CPRX
Catalyst Pharmaceuticals

Last Price:
14.71
Seasonality Move:
10.94%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
133.68
Seasonality Move:
16.32%
Sell
42
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $14.72. The Score for CPRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.66. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $14.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 42.69 Sell
Chaikin Money Flow: -1085975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.93 - 15.65) Sell
Bollinger Bands (100): (14.1 - 16.22) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.64 Buy
Relative Strength Index (14 RSI): 67.1 Buy
Chaikin Money Flow: 612520 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.36 - 129.54) Buy
Bollinger Bands (100): (105.79 - 132.01) Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.99 Sell
20-day SMA: 15.27 Sell
50-day SMA: 15.62 Sell
200-day SMA: 14.25 Buy
8-day EMA: 15.01 Sell
20-day EMA: 15.2 Sell
50-day EMA: 15.28 Sell
200-day EMA: 14.61 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.85 Buy
20-day SMA: 123.86 Buy
50-day SMA: 125.76 Buy
200-day SMA: 112.16 Buy
8-day EMA: 128.57 Buy
20-day EMA: 125.83 Buy
50-day EMA: 124.03 Buy
200-day EMA: 116.7 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.76 per share, an increase next quarter of $3.62 per share, an increase this year of $6.80 per share, and an increase next year of $5.63 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):